Dose-reduced FCR first-line therapy in fit elderly CLL patients is safe, tolerable, and highly effective; first report of final statistical analysis from end of study and 12 month follow-up of ALLG CLL5 randomised dose de-escalation study
LEUKEMIA & LYMPHOMA(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要